![Britton Russell](https://www.umoja-biopharma.com/wp-content/uploads/2024/02/Britton_Russell.jpg)
Britton Russell
Chief Financial Officer
Britton Russell is the Chief Financial Officer at Umoja Biopharma. Britton previously held Chief Financial Officer positions at Parse Biosciences, a single-cell sequencing company, and Genapsys, a DNA sequencing company. Prior, Britton served as Senior Vice President of Finance at ArcherDX, a genomic analysis company and later Invitae, after it acquired ArcherDX. He has also held a diverse range of corporate finance roles at AstraZeneca, Genentech/Roche, and Royal Dutch Shell.
Britton holds an MBA from Rice University, and a BS in Finance and a BA in Business and Sustainability from Arizona State University.